Electronic Health Reporter

By Jiang Li, CEO, Vivalink.

In the years that have passed since the COVID-19 pandemic, hospital executives have been examining the promises of remote patient monitoring (RPM), telehealth, and hospital-at-home (HaH) services with more intense scrutiny. No longer under pressure to adopt these technologies at any cost, health leaders are looking for hard evidence that they improve ROI.

But health systems may be defining financial returns too narrowly. Many of their evaluations measure RPM against a narrow set of financial indicators: reduced admissions, fewer readmissions, and incremental reimbursement capture. But patient data from mature programs points to gains in areas hospitals rarely built their ROI models around in the first place: clinician time recovered, care escalation caught earlier, and patient adherence sustained past the point where in-person follow-up would have lapsed. If the measurement framework was built for 2020’s pilot programs, it will keep returning the wrong verdict on 2026’s operational reality.

The Other Side of ROI

The biggest disconnect between the metrics that dominate RPM evaluations and the way RPM actually improves ROI comes from focusing too much on counting admissions and reimbursement. RPMs are most useful for reducing the size, scale, and intensity of the resource allocation required per patient. Counting admissions doesn’t capture that data nor does it show where RPM is most effective.

Clinician time is the clearest example. A nurse monitoring 80 patients through a well-tuned RPM platform is not doing the same job as a nurse making 80 individual phone calls. The platform absorbs the routine checking, the vitals review, the flagging of normal readings as normal, so clinical staff spend their attention on patients who most need it. That time recovered rarely appears on a P&L, but it shows up in retention, in burnout rates, and in how many patients a care team can safely manage without adding headcount.

Care escalation timing tells a similar story. RPM programs built around this benefit are catching the early signals of disease in a weight trend, a blood pressure drift, or a symptom pattern before it becomes an emergency department visit or an inpatient stay. RPM can completely change the point of clinical intervention.

Adherence sustained over time is the least visible of the three, and possibly the most durable. Most in-person follow-up has a natural expiration date. Patients stop coming back, or spacing between visits widens, and engagement drops. Continuous monitoring extends that window, and programs with strong adherence data are seeing patients stay connected to their care team months past where a conventional follow-up schedule would have let them drift.

None of this shows up cleanly in a standard ROI model built around admissions and reimbursement. These are useful overall markers of a facility’s care volume and expense, but they don’t capture each patient’s complete care footprint.

Modernizing the Measurement Toolkit

To capture these hidden gains, health systems must look beyond billing data and standard claims registries. Shifting to a realistic evaluation framework starts with workflow and capacity analytics. Instead of simply measuring clinical hours worked, platform data can track time-per-patient-managed and panel size capacity. Comparing the time clinicians spend on exception-based monitoring versus traditional, reactive phone outreach quantifies labor savings, showing exactly how many more patients a single care team can safely manage without increasing headcount or accelerating burnout.

Measuring the true financial impact also requires shifting from short-term, 30-day readmission windows to longitudinal cost tracking. Total-cost-of-care models that follow patients over six to 12 months reveal the compounding value of remote monitoring, contrasting the low cost of proactive, early medication adjustments against the high price of averted emergency room crises. Furthermore, tracking long-term adherence helps systems quantify reduced patient leakage. When continuous engagement keeps individuals from dropping out of the care network to seek treatment elsewhere, the lifetime value of that retained patient directly offsets the initial technology investment.

To effectively measure RPM ROI, executive leadership should consider replacing P&L statements with a balanced value scorecard. A unified dashboard should weigh clinical stabilization and staff retention alongside traditional reimbursement. When evaluating program performance, operational resilience and workforce stability must carry the same financial weight as direct revenue generation to reveal the true return on investment.